This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout
Rights and permissions
About this article
Cite this article
Daniel, P., Prichard, M. The Response of Experimentally Induced Mammary Tumours in Rats to Hypophysectomy and to Pituitary Stalk Section. Br J Cancer 17, 446–453 (1963). https://doi.org/10.1038/bjc.1963.59
Issue date:
DOI: https://doi.org/10.1038/bjc.1963.59
This article is cited by
-
Effects of the luteinizing-hormone-releasing hormone (LHRH) antagonist ramorelix (hoe013) and the LHRH agonist buserelin on dimethylbenz[a]anthracene-induced mammary carcinoma: studies with slow-release formulations
Journal of Cancer Research and Clinical Oncology (1993)
-
Treatment of experimental DMBA induced mammary carcinoma with Cetrorelix (SB-75): a potent antagonist of luteinizing hormone-releasing hormone
Journal of Cancer Research and Clinical Oncology (1992)
-
Metabolism of Labelled Carcinogenic Hydrocarbons in Rats
Nature (1967)